Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Wieduwilt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Personalized Medicine|February 25, 2022
Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and OutcomesTaha Al-Juhaishi, Azra Borogovac, Sami Ibrahimi, et al.
Case Reports in Hematology|July 14, 2015
Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell TransplantationJulia Tomlin, Ryan K Orosco, Sarah Boles, et al.
JCO Precision Oncology|July 7, 2017
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid MalignanciesAaron M Goodman, Michael Choi, Matthew Wieduwilt, et al.
Cancers|December 26, 2018
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsNatalie Galanina, Rafael Bejar, Michael Choi, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Blood Advances|November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017Patrick A Brown, Bijal Shah, Amir Fathi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyPatrick A Brown, Bijal Shah, Anjali Advani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Personalized Medicine|February 25, 2022
Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and OutcomesTaha Al-Juhaishi, Azra Borogovac, Sami Ibrahimi, et al.
Case Reports in Hematology|July 14, 2015
Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell TransplantationJulia Tomlin, Ryan K Orosco, Sarah Boles, et al.
JCO Precision Oncology|July 7, 2017
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid MalignanciesAaron M Goodman, Michael Choi, Matthew Wieduwilt, et al.
Cancers|December 26, 2018
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsNatalie Galanina, Rafael Bejar, Michael Choi, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Blood Advances|November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017Patrick A Brown, Bijal Shah, Amir Fathi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyPatrick A Brown, Bijal Shah, Anjali Advani, et al.
Pageof 2